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16th March 2017 
Dear Editor, 
We thank Park et al for their interest in our work and for bringing to our attention their 
alternative microenvironmental score for assessing colorectal cancer prognosis. 1-3  We are 
largely in agreement with many of the points raised. The scoring systems proposed by these 
two studies share many similarities, highlighting the importance of the non-epithelial 
tumour components and combining assessments of peritumoral inflammatory response and 
tumour stromal percentage to derive a prognostically valuable fibroinflammatory or 
microenvironmental score. Despite the overall similarity, a number of small, albeit clinically 
important, differences lie in the methodologies chosen for assessment of each individual 
parameter, and in the statistical approaches used. 
As Park et al acknowledge, there is considerable evidence that it is the lymphoid 
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composition of the peritumoral inflammatory population (rather than general inflammation) 
that is of most prognostic influence for colorectal cancer, although reproducibility is likely 
inferior. 4-7  Their working group have previously reported assessment of both peritumoral 
lymphocytic inflammation (by Jass method) and general inflammation (by Klintrup-Makinen 
method) to have good reproducibility (inter-observer intraclass correlation coefficients 0.71 
and 0.81 respectively). 8 Although we found good intraobserver reproducibility, we also 
observed poor interobserver reproducibility for assessment of peritumoral lymphoid 
infiltrates, and did not evaluate general peritumoral inflammation in our study. There are a 
growing number of translational studies highlighting that the prognostic value of the 
inflammatory microenvironment can be dictated by the relative abundance of specific 
immune-cell lineages. 9-11  We acknowledge that general inflammation may indeed be more 
easily and reproducibly assessed on haematoxylin and eosin (H&E)-stained slides and that 
immunohistochemistry, aided by digital image analysis, may be required for most accurate 
immunoscoring of lymphoid populations. This is deserved of further study.  
 
A further distinction between the two studies is that, unlike the microenvironmental score 
proposed by Park et al, our score includes an assessment of peritumoral lymphoid 
aggregates, or Crohn’s disease-like reaction (CLR). Supported by Klintrup et al, we consider 
this sufficiently independent of peritumoral diffuse lymphoid reaction to warrant inclusion 
as a separate parameter, adding prognostic value.  12  Our study employed the well-
established semi-quantitative assessment proposed by Graham and Appelman, which we 
found to be reproducible. 13  The cited study by Kim et al advocates assessment of 
peritumoral lymphoid aggregates by size or density. 14  However this study methodology 
employed digital image analysis of scanned slides, to allow the required precise 
measurements for this classification, and is therefore not immediately applicable to routine 
histopathology practice at the current time. For this reason, this method of assessment was 
not considered in our study. 
We adopted both global and focal assessments of tumour stromal percentage (TSP), as 
reported previously.  15-17  We found global, but not focal, assessment to be highly 
reproducible and prognostic. As discussed, we are aware this contradicts findings from two 
previous studies also highlighted by Park et al, both describing excellent reproducibility of 
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the refined focal method. 16,17  Key to the focal TSP method is identification of the most 
invasive point of tumour and, on post-study case discussion, this varied considerably 
between the four pathologists in our study, profoundly influencing assessments and 
reproducibility. This is likely to be an even greater problem in everyday reporting practice, 
with more tumour slides to evaluate per case. Also taking into consideration frequent 
heterogeneity of tumour morphology, we consider the global TSP method to be more 
valuable than the focal TSP method. 
Finally, some differences in the statistical approaches to the two scores also exist. Park et al 
evaluated five year survival, whereas we evaluated prognosis up to ten years post-diagnosis, 
and retained confounders such as adjuvant chemotherapy in our multivariate model. They 
found TSP to be rare and not prognostic in a scenario of high general inflammation 
(Klintrup-Makinen) score. 3  Leaving aside the differences in assessment methodologies 
outlined above, we have now replicated this analysis, and also found a high global TSP to be 
of greater prognostic importance in the context of low peritumoral inflammation 
(unadjusted HR 1.63, 95% CI 1.11-2.40).  However, as outlined in Table 5 of our results, 
taking into consideration all three measures (global TSP, peritumoral inflammation and CLR) 
resulted in the strongest association with colorectal cancer-specific survival.  Perhaps of 
most importance, in multivariate models, we found a stronger association between 
colorectal cancer-specific survival and the highest fibroinflammatory score in our study (HR 
2.44, 95% CI 1.56-3.81), than that noted for the highest Glasgow microenvironmental score 
(HR 1.93, 95% CI 1.36-2.73), although the confidence intervals do overlap. 3   
Despite differences in methodologies employed, the similar approaches adopted by the two 
groups draw similar conclusions and further highlight the potential utility of inflammatory 
and stromal assessments as valuable prognostic markers in colorectal cancer, alone or in 
some combination. We agree further independent studies are required for validation and 
determination of optimal methods of assessment.  
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Yours sincerely, 
Dr. Seán O Hynes1,  
Dr. Helen G Coleman2,  
Dr. Paul J Kelly1,3,  
Dr. Philip D Dunne1,  
Professor Manuel Salto-Tellez1,3  
Dr. Maurice B Loughrey1,3 
1Northern Ireland Molecular Pathology Laboratory, Centre for Cancer Research and Cell 
Biology, Belfast, UK. 2Centre for Public Health, Queen’s University Belfast, UK. 3Department 
of Tissue Pathology, Royal Victoria Hospital, Belfast Health and Social Care Trust, Belfast, UK. 
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